Posterna et al. conjugated BRAF inhibitor BI-882370 and CRBN ligand to synthesize the PROTAC P4B, which specifically suppressed melanoma and colorectal cancer cells harboring BRAFV600E or other BRAF mutations [60]. Here, BRAF is linked to melanoma.